alexa Abstract | Association of bronchiectasis and gastroesophageal reflux

Current Pediatric Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


This study represents the experience of a tertiary care center in Saudi Arabia on association of non-cystic fibrosis bronchiectasis and gastroesophageal reflux (GER). A retrospective review of all patients with GER and Non-Cystic Fibrosis (Non-CF) Bronchiectasis was done in a pulmonary clinic for the period 1993-2005. A total of 49 patients were found to have both conditions. Twenty six (53%) were males, 23 (47%) were females. 48 (98%) are alive and 1(2%) died. The southwestern regions contributed to 29(60%) of the cases. There is a period of 5± 3.2 years between the start of symptoms and the diagnosis of bronchiectasis. More than 2/3 of the patients had cough, tachypnea, wheezing, sputum production and failure to thrive. 30(61%) had associated disease: Pulmonary diseases in 22(45%), Immunodefficiency in 5(18%), CNS in 9 (18%), and cardiac in 3 (6%). Left lower lobes (LLL) was commonly involved in 38(76%). Asthma was found in 41(84%) of the patients. Twenty five (51%) of 49 patients found to have sinusitis. Hemophilus influenza (H-flue) was cultured in 16(33%), Streptococcus pneumoniae in 3 (6%), pseudomonas aeruginosa in 7(14%). Twenty two of 49 patients (92%), who were able to do PFT, had abnormal changes. Disease progression developed in 32 (65%) of the patients. GER was directly related to early development of symptoms. The diagnosis of bronchiectasis was delayed with the presence of CNS anomalies (p <0.05). GER is commonly associated with Non-CF bronchiectasis. Early recognition and institution of treatment will prevent progression of the disease.

To read the full article Peer-reviewed Article PDF image

Author(s): Hanaa Hasan Banjar


Bronchiectasis, Gastresophageal reflux, Developing countries

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version